We are live on ! Find out more
LD

Lipe & Dalton Portfolio holdings

AUM $215M
1-Year Est. Return 39.53%
This Fund
S&P 500
This Quarter Est. Return
+13.22%
1 Year Est. Return
+39.53%
3 Year Est. Return
+89.64%
5 Year Est. Return
+111.74%
10 Year Est. Return
+427.59%
AUM
$174M
AUM Growth
+$14.4M
Cap. Flow
-$2.53M
Cap. Flow %
-1.45%
Top 10 Hldgs %
37.93%
Holding
107
New
5
Increased
18
Reduced
52
Closed
7

Top Buys

Rank Stock Value
1
MRNA icon
Moderna
MRNA
+$2.39M
2
BAM icon
Brookfield Asset Management
BAM
+$1.02M
3
EW icon
Edwards Lifesciences
EW
+$212K
4
QCOM icon
Qualcomm
QCOM
+$171K
5
SWK icon
Stanley Black & Decker
SWK
+$68.3K

Top Sells

Rank Stock Value
1
AMED
Amedisys
AMED
+$2.22M
2
BN icon
Brookfield
BN
+$1.13M
3
PARA
Paramount Global Class B
PARA
+$846K
4
ROG icon
Rogers Corp
ROG
+$242K
5
BAX icon
Baxter International
BAX
+$241K

Sector Composition

Rank Sector Weight
1 Healthcare 20.6%
2 Technology 18.9%
3 Industrials 18.17%
4 Financials 14.85%
5 Consumer Staples 7.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LMT icon
26
Lockheed Martin
LMT
$134B
$2.45M 1.41%
5,045
-30
-0.6% -$13.9K
ETN icon
27
Eaton
ETN
$157B
$2.34M 1.35%
14,902
-20
-0.1% -$3.07K
CBRE icon
28
CBRE Group
CBRE
$40.8B
$2.24M 1.29%
29,078
-120
-0.4% -$8.86K
BKNG icon
29
Booking.com
BKNG
$138B
$2.12M 1.22%
26,300
+125
+0.5% +$9.49K
CI icon
30
Cigna
CI
$76.6B
$2.08M 1.2%
6,283
+21
+0.3% +$6.64K
V icon
31
Visa
V
$677B
$1.97M 1.14%
9,502
-70
-0.7% -$14.1K
SYF icon
32
Synchrony
SYF
$23.7B
$1.97M 1.13%
59,927
-285
-0.5% -$9.76K
MLM icon
33
Martin Marietta Materials
MLM
$33.6B
$1.95M 1.12%
5,755
-120
-2% -$40.9K
TRP icon
34
TC Energy
TRP
$73.5B
$1.89M 1.09%
47,325
+172
+0.4% +$7.46K
MSFT icon
35
Microsoft
MSFT
$2.84T
$1.75M 1.01%
7,318
-435
-6% -$104K
J icon
36
Jacobs Solutions
J
$15.9B
$1.61M 0.93%
16,193
-242
-1% -$23.8K
VRTX icon
37
Vertex Pharmaceuticals
VRTX
$121B
$1.5M 0.86%
5,185
-50
-1% -$15.2K
CVS icon
38
CVS Health
CVS
$137B
$1.45M 0.83%
15,523
-148
-0.9% -$14.3K
HSY icon
39
Hershey
HSY
$35.4B
$1.37M 0.79%
5,925
-35
-0.6% -$8.07K
MRK icon
40
Merck
MRK
$324B
$1.33M 0.76%
11,971
+1
+0% +$102
STZ icon
41
Constellation Brands
STZ
$22.2B
$1.32M 0.76%
5,706
– –
BAX icon
42
Baxter International
BAX
$11.6B
$1.31M 0.75%
25,655
-4,487
-15% -$241K
JNJ icon
43
Johnson & Johnson
JNJ
$635B
$1.26M 0.73%
7,149
+1
+0% +$173
PRU icon
44
Prudential Financial
PRU
$41.7B
$1.23M 0.71%
12,393
-123
-1% -$12.5K
COO icon
45
Cooper Companies
COO
$13.7B
$1.13M 0.65%
13,680
+220
+2% +$16.2K
QCOM icon
46
Qualcomm
QCOM
$176B
$1.05M 0.6%
9,530
+1,460
+18% +$171K
BAM icon
47
Brookfield Asset Management
BAM
$74B
$976K 0.56%
+34,042
New +$1.02M
MDT icon
48
Medtronic
MDT
$107B
$960K 0.55%
12,356
-399
-3% -$32.3K
AMZN icon
49
Amazon
AMZN
$2.5T
$916K 0.53%
10,900
+550
+5% +$54.3K
BCE icon
50
BCE
BCE
$19.9B
$883K 0.51%
20,100
-300
-1% -$13.5K
1
2
3 4 5

Similar funds

VEA
Virtus ETF Advisers New York $215M AUM 53.68% 1-Year Est. Return
NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
GC
GatePass Capital Independence, Ohio $214M AUM 29.83% 1-Year Est. Return

Lipe & Dalton's Q4 2022 Portfolio in Review

As of Q4 2022, Lipe & Dalton held 107 positions worth $174M, up 9% from $159M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Lipe & Dalton's Q4 2022 filing shows 5 new, 18 increased, 52 reduced and 7 closed positions. Its largest new stake was Moderna: 14,644 shares worth $2.63M. The largest sale was Amedisys, an estimated $2.22M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 21% a quarter earlier, followed by Technology and Industrials.

  • Lipe & Dalton's largest Q4 2022 buy was Moderna: 14,644 shares worth $2.63M.
  • Lipe & Dalton added most to Qualcomm in Q4 2022, an estimated $171K increase.
  • Lipe & Dalton's biggest Q4 2022 reduction was Brookfield, cutting an estimated $1.13M.
  • Lipe & Dalton fully exited Amedisys in Q4 2022, selling an estimated $2.22M.
  • Lipe & Dalton's ten largest holdings make up 38% of its $174M portfolio in Q4 2022.
  • Lipe & Dalton opened 5 new positions and closed 7 in Q4 2022.
  • Lipe & Dalton's portfolio value rose 9% quarter-over-quarter to $174M.

Based on Lipe & Dalton's 13F filing for Q4 2022, filed 3 Feb 2023.